6533b82bfe1ef96bd128d6cf

RESEARCH PRODUCT

Drug-induced oral lichenoid reactions: a literature review

José Vicente Bagán SebastiánYolanda Jiménez SorianoPedro Serrano SánchezMaría Gracia Sarrión Pérez

subject

DrugPathologymedicine.medical_specialtyNonsteroidalbiologybusiness.industrymedia_common.quotation_subjectAngiotensin-converting enzymeOdontologíamedicine.disease:CIENCIAS MÉDICAS [UNESCO]DermatologyCiencias de la saludchemistry.chemical_compoundstomatognathic diseaseschemistryUNESCO::CIENCIAS MÉDICASbiology.proteinMedicineLichenoid reactionsOral lichen planusbusinessGeneral DentistryLichenoid lesionsmedia_common

description

The terms oral lichenoid reactions or oral lichenoid lesions refer to lesions histologically and clinically similar to oral lichen planus, though with the particularity that in these cases the underlying cause is identifiable. In addition, these lesions are described according to the causal factor involved, including alterations resulting from direct contact with dental restoration materials, drug-related lesions, and lesions associated to graft-versus-host disease. Drug-induced oral lichenoid reactions or oral lichenoid lesions were first cited in 1971 by Almeyda and Levantine. Since then, many drug substances have been associated with such lesions. The most common agents are nonsteroidal antiinflammatory drugs and angiotensin converting enzyme inhibitors.

http://hdl.handle.net/10550/54516